AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5114.12M
Enterprise Value 3111.61M
Trailing P/E N/A
Forward P/E 1-4.44
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)19.04
Price/Book (mrq)N/A
Enterprise Value/Revenue 318.62
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.73
52-Week Change 3-66.31%
S&P500 52-Week Change 36.90%
52 Week High 33.5900
52 Week Low 30.4900
50-Day Moving Average 30.7260
200-Day Moving Average 30.9260

Share Statistics

Avg Vol (3 month) 32.63M
Avg Vol (10 day) 32.66M
Shares Outstanding 5119.03M
Float 134.83M
% Held by Insiders 10.28%
% Held by Institutions 132.51%
Shares Short (Jun 28, 2019) 421.74M
Short Ratio (Jun 28, 2019) 46.89
Short % of Float (Jun 28, 2019) 416.12%
Short % of Shares Outstanding (Jun 28, 2019) 413.52%
Shares Short (prior month May 31, 2019) 422.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 70.30%
Operating Margin (ttm)-445.98%

Management Effectiveness

Return on Assets (ttm)-47.65%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)5.99M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)57.00%
Gross Profit (ttm)-15.24M
EBITDA N/A
Net Income Avi to Common (ttm)4.21M
Diluted EPS (ttm)-0.1790
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.48M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)19.2M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.39
Book Value Per Share (mrq)-0.13

Cash Flow Statement

Operating Cash Flow (ttm)-26.96M
Levered Free Cash Flow (ttm)-20.42M